FDA Investigator: Blackstone Hill, Jean
- Blackstone Hill, Jean first started conducting FDA inspections in 2000, with the last inspection in 2002. Over that time, Blackstone Hill, Jean has conducted 7 inspections at 7 companies across 7 sites.
Get Blackstone Hill, Jean's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Eli Lilly And Company, Indianapolis | 2002
Out-of-stock
Blackstone Hill, Jean
Human Drug Form 483
FDA 483 Scientech Laboratories Inc, S Plainfield | 2001
Out-of-stock
Blackstone Hill, Jean
Human Drug Form 483
FDA 483 Intertek USA Inc. d/b/a QTI, Inc., Whitehouse | 2001
Out-of-stock
Blackstone Hill, Jean
Human Drug Form 483
FDA 483 Noramco, Inc., Wilmington | 2001
Out-of-stock
Blackstone Hill, Jean
Human Drug Form 483
FDA 483 Mutual Pharmaceutical Company, Inc., Philadelphia | 2000
Out-of-stock
Blackstone Hill, Jean
Human Drug Form 483
Co-Investigators (12)
- Susan P. Bruederle, FDA Investigator
- Patricia H. Dlugosz, FDA Investigator
- Charles I. Ahn, FDA Investigator
- Jean Blackstone Hill, FDA Investigator
- Daniel J. Grabicki, FDA Investigator
- Erin D. McCaffery, FDA Investigator
- Ernest Bizjak, FDA Investigator
- Amy L. Singer, FDA Investigator
- Luis A. Dasta, FDA Investigator
- Vlada Matusovsky, FDA Investigator
- Tammy L. Chavis, FDA Investigator
- Debra J. Bennett, FDA Investigator